Astellas and Chromocell Enter License and Collaboration Agreement for Neurophatic and Pain Therapeutics Life Science Investing
Turing Pharmaceuticals Backtracks After 5,000-percent Price Increase for Daraprim Pharmaceutical Investing
Mayne Pharma Starts Construction on $65 Million Facility for Pharmaceutical Manufacturing Life Science Investing
Big Pharma Pushes Forward with Alzheimer's R&D but Medicinal Plants May be the Answer Pharmaceutical Investing
International Stem Cell Corporation and Rohto Pharmaceutical Enter Second Stage of Research Agreement Biotech Investing
